Healthcare utilization and costs for patients initiating Dabigatran or Warfarin
Crossref DOI link: https://doi.org/10.1186/s12955-017-0705-x
Published Online: 2017-06-21
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reynolds, Shannon L.
Ghate, Sameer R.
Sheer, Richard
Gandhi, Pranav K.
Moretz, Chad
Wang, Cheng
Sander, Stephen
Costantino, Mary E.
Annavarapu, Srinivas
Andrews, George
Funding for this research was provided by:
Boehringer Ingelheim
Humana Inc